SYK 📈 Stryker - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8636671013
SYK: Medical Implants, Surgical Equipment, Patient Care Products, Orthopedic Devices
Stryker Corporation is a medical technology company that operates through two primary segments: MedSurg and Neurotechnology, and Orthopaedics and Spine. The company's Orthopaedics and Spine segment is focused on developing and manufacturing implants used in total joint replacements, such as hip, knee, and shoulder surgeries, as well as trauma and extremities procedures. This segment also offers a range of spinal implant products, including cervical and thoracolumbar systems, which are designed to provide fixation, minimally invasive, and interbody solutions for spinal injuries, complex spine conditions, and degenerative therapies. Additionally, the company's Orthopaedics and Spine segment provides a variety of orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation systems, which are used to promote bone growth and repair.
The MedSurg and Neurotechnology segment, on the other hand, offers a broad range of medical devices and equipment, including surgical navigation systems, endoscopic systems, patient handling equipment, emergency medical equipment, and intensive care disposable products. This segment also provides neurosurgical, neurovascular, and craniomaxillofacial implant products, which are used in minimally invasive endovascular procedures, brain and open skull-based surgical procedures, and other complex neurosurgical applications. Furthermore, the company offers a variety of clinical communication and workflow solutions, as well as patient and caregiver safety technologies, which are designed to improve patient outcomes and reduce the risk of adverse events. The MedSurg and Neurotechnology segment also includes reprocessed and remanufactured medical devices, which provide a cost-effective and sustainable alternative to traditional medical devices.
Stryker Corporation sells its products to a global customer base, including doctors, hospitals, and other healthcare facilities, through a network of company-owned subsidiaries and branches, as well as third-party dealers and distributors. The company's products are available in approximately 75 countries, and its global reach is supported by a strong distribution network and a commitment to customer service. With a history dating back to 1941, Stryker Corporation has established itself as a leading player in the medical technology industry, with a reputation for innovation, quality, and customer satisfaction. The company is headquartered in Portage, Michigan, and its common stock is listed on the New York Stock Exchange (NYSE) under the ticker symbol SYK.
As a leading medical technology company, Stryker Corporation is committed to developing and manufacturing innovative products that improve patient outcomes and enhance the quality of life. The company's products and services are designed to address a wide range of medical needs, from orthopaedic and spinal implants to neurosurgical and neurovascular devices. With a strong focus on research and development, Stryker Corporation is constantly seeking new and innovative solutions to complex medical problems, and its products and services are used by healthcare professionals around the world to improve patient care and outcomes. The company's website, https://www.stryker.com, provides more information about its products, services, and mission, as well as its financial performance and corporate governance.
Additional Sources for SYK Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
SYK Stock Overview
Market Cap in USD | 142,804m |
Sector | Healthcare |
Industry | Medical Devices |
GiC Sub-Industry | Health Care Equipment |
IPO / Inception | 1988-02-01 |
SYK Stock Ratings
Growth 5y | 70.9% |
Fundamental | 50.9% |
Dividend | 58.1% |
Rel. Strength Industry | 907 |
Analysts | 4.06/5 |
Fair Price Momentum | 370.08 USD |
Fair Price DCF | 217.51 USD |
SYK Dividends
Dividend Yield 12m | 0.88% |
Yield on Cost 5y | 1.59% |
Annual Growth 5y | 7.39% |
Payout Consistency | 95.0% |
SYK Growth Ratios
Growth Correlation 3m | 66.6% |
Growth Correlation 12m | 69.8% |
Growth Correlation 5y | 86% |
CAGR 5y | 12.60% |
CAGR/Mean DD 5y | 1.58 |
Sharpe Ratio 12m | 1.00 |
Alpha | -5.83 |
Beta | 1.17 |
Volatility | 22.24% |
Current Volume | 3146.7k |
Average Volume 20d | 1266.5k |
As of December 21, 2024, the stock is trading at USD 364.60 with a total of 3,146,693 shares traded.
Over the past week, the price has changed by -4.78%, over one month by -8.11%, over three months by -1.95% and over the past year by +23.49%.
Partly, yes. Based on ValueRay Fundamental Analyses, Stryker (NYSE:SYK) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 50.91 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SYK as of December 2024 is 370.08. This means that SYK is currently overvalued and has a potential downside of 1.5%.
Stryker has received a consensus analysts rating of 4.06. Therefor, it is recommend to buy SYK.
- Strong Buy: 13
- Buy: 9
- Hold: 9
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, SYK Stryker will be worth about 411.3 in December 2025. The stock is currently trading at 364.60. This means that the stock has a potential upside of +12.81%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 403.7 | 10.7% |
Analysts Target Price | 317.1 | -13% |
ValueRay Target Price | 411.3 | 12.8% |